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Obesity leads to adipose tissue dysfunction, insulin resistance and diabetes. Adipose tissue 
produces adipokines,that contribute to regulate insulin sensitivity. In turn insulin stimulates 
the production and release of some adipokines.  Casitas-b-lymphoma proteins (c-Cbl, Cbl-b 
and Cbl3) are intracellular adaptor signalling proteins that are rapidly phosphorylated by 
activation of tyrosine kinase receptors. c-Cbl is rapidly phosphorylated by insulin in 
adipocytes. Here we tested the hypothesis that Cbl signalling regulates adipokine expression 
in adipose tissue.  We determined the adipokine profile of WAT of Cbl-/- and Cbl+/+ mice in 
the C57BL6 background. Female Cbl-/- mice exhibited altered expression of adiponectin, 
leptin and RBP4 in visceral adipose tissue while no significant changes were seen in male 
mice. TNFα and IL6 levels were unaffected by Cbl depletion. RBP4 expression was 
unchanged in liver. Adipose tissue of Cbl-/- animals showed increased basal activation of 
extracellular regulated kinases (ERK1/2) compared to Cbl+/+. c-Cbl knockdown in 3T3L1 
adipocytes also increased basal ERK phosphorylation and RBP4 expression. Inhibition of 
ERK1/2 phosphorylation in Cbl-depleted 3T3L1 adipocytes or in adipose tissue explants of 
Cbl-/- mice reduced RBP4 mRNA. 17β-estradiol increased RBP4 mRNA in adipocytes.  Cbl 
depletion did not change ER expression but increased phosphorylation of ERα at S118, a 
target site for ERK1/2. ERK1/2 inhibition reduced phosphoER and RBP4 levels. These 
findings suggest that Cbl contributes to regulate RBP4 expression in adipose of female mice 
through ERK1/2-mediated activation of ERα. Since Cbl signalling is compromised in 








Casitas b-lymphoma (Cbl) is a proximal insulin receptor adaptor protein identified as 
necessary for insulin-mediated activation of glucose transport in adipocytes (Baumann, et al. 
2000; Chang, et al. 2002; Chiang, et al. 2001; Liu, et al. 2003; Liu, et al. 2002). Three Cbl 
isoforms are present in mammalian cells (c-Cbl, Cbl-b and Cbl3). Cbl3 is a truncated isoform 
present  only in the skin, while c-Cbl and Cbl-b are quite ubiquitous and become rapidly 
phosphorylated on tyrosine residues in response to insulin and other growth factors c-Cbl is 
the predominant isoform expressed in mature adipocytes (Liu et al. 2003). We reported that 
C-Cbl (hereafter Cbl) is also quickly phosphorylated by insulin in vivo in heart and skeletal 
muscle albeit in these tissues it appears to regulate other intracellular proteins (Gupte and 
Mora 2006). Cbl phosphorylation and expression is compromised in diabetic animal models 
(Gupte and Mora 2006). In addition, Cbl proteins also contain a RING finger domain that 
allows them to function as E3-Ubiquitin ligase enzymes and thus facilitate protein 
degradation. Whole body disruption of c-Cbl gene in mice in the Jvs129 background resulted 
in reduced fat peripheral stores and increased fatty acid oxidation in skeletal muscle and 
whole body insulin sensitivity (Molero, et al. 2004).These mice were also exhibited 
resistance to the deleterious effects of a high fat diet (Molero, et al. 2006).  
 
White adipose tissue (WAT) has an important role in maintaining glucose and lipid 
homeostasis and thus in maintaining health. WAT is a dynamic tissue that stores surplus 
energy in the form of triglycerides, but it also produces a plethora of bioactive  molecules 
collectively called adipokines that help regulate biological functions in other cells and organs. 
Some of these proteins like adiponectin increase insulin sensitivity in peripheral organs, 
some arepro-inflammatory such as IL6 or TNFa and  inhibit insulin action and others like 




Adiponectin  (also called ACRP30) is an adipokine with insulin sensitizing functions in liver 
and skeletal muscle (Berg, et al. 2002; Kadowaki, et al. 2006; Yamanuchi, et al. 2002), as 
well as  anti-inflammatory (Mandal, et al. 2011; Ohashi, et al. 2010; Takemura, et al. 2007) 
and anti-atherogenic effects (Lovren, et al. 2010; Okamoto, et al. 2008; Okamoto, et al. 
2002; Ouchi, et al. 2001). Adiponectin circulating levels are inversely correlated with BMI,  
visceral adiposity  and insulin resistance (Arita, et al. 1999; Bouatia-Naji, et al. 2006; Pajvani 
and Scherer 2003)  (For a recent reviews see (Kwon and Pessin 2013) (Ohashi, et al. 2014; 
Ohashi, et al. 2015; Ouchi, et al. 2011) ) 
  
Leptin is a small WAT adipokine that regulates feeding behaviour through the hypothalamic 
regulation in central nervous system (Zhang, et al. 1994). Leptin plasma levels are elevated 
in obese rodents and humans due to increased adipose tissue content and leptin resistance 
(Friedman and Halaas 1998). Leptin stimulates monocytes and macrophages to produce 
pro-inflammatory cytokines including: IL6, TNFa, and IL12(Gainsford, et al. 1996) and 
stimulates CCL2 production in human hepatic stellate cells (Aleffi, et al. 2005). 
 
Retinol Binding Protein 4 (RBP4) is both an adipokine and liver-derived protein that 
transports retinol (vitamin A) in the blood (Tamori, et al. 2006). It has been implicated in the 
metabolic syndrome and adipose tissue inflammation (Boyraz, et al. 2013; Kovacs, et al. 
2007). RBP4 expression in adipose tissue correlates positively with inflammation (Yao-
Borengasser, et al. 2007), expression of pro-inflammatory cytokines and adiposity (Klöting, 
et al. 2007) and inversely with GLUT4 protein levels (Yang, et al. 2005). Recombinant RBP4 
administration  induced insulin resistance in mice (Yang et al. 2005). RBP4 levels are 
increased in obese and insulin-resistant humans (Graham, et al. 2006) and  mouse models. 
Genetic (Moraes-Vieira, et al.2014) or pharmacologic elevation of serum RBP4 causes 
insulin resistance and  hepatic steatosis in mice (Lee, et al.2016). Recent studies in 
transgenic mice models overexpressing Rbp4gene in adipose tissue have revealed that 
RBP4  causes inflammation in adipose tissues by activating macrophages independently of 
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its retinol binding status and via activation of the Toll-like 4 receptor (Norseen, et al. 2012), 
as well as activating  innate immunity (Moraes-Vieira, et al. ; Moraes-Vieira et al.). 
 
Here, we tested the hypothesis that Cbl signalling in adipose tissue may regulate adipokine 
expression.  We examined the expression  and circulating levels of several adipokines 
involved in insulin sensitivity in the c-Cbl null animal model and their wild type littermates and 
their expression in c-Cbl knocked-down 3T3L1 adipose cells. We report that Cbl depletion in 
adipocytes increases basal activation of extracellular regulated kinases (ERK1/2) and results 
in enhanced expression of RBP4 in adipocytes of female mice via activation of the estrogen 
receptor.  
 
Materials and methods  
Reagents plasmids and antibodies: Tissue culture reagents (FBS, trypsin, 
penicillin/streptomycin, insulin, IBMX, dexamethasone, puromycin, 17-β estradiol) were from 
Sigma-Aldrich. MEK1/2 inhibitors PD98059 and U0126 were obtained from Sigma-Aldrich. 
Adipokine ELISA kits for RBP4 (cat. Number DY3476, assay range: 93.8-6000 pg/ml), 
Adiponectin (cat. Number DY1119, assay sensitivity 31-2000 pg/ml) and leptin (cat. Number 
DY498, assay range 125-8000 pg/ml ) were from R&D Systems (Minneapolis, Minnesota 
USA) , IL6 (cat. Numbers capture: detection:  from and TNFa (cat number from BD 
Biosciences) ELISA antibodies were from Thermofisher Scientific and used at 2ug/ml). The 
PKLO.1 puro empty plasmid (cat number SHC001), the PKLO.1 plasmid carrying a non-
targeting shRNA (NT shRNA) sequence (cat SHC002) and PKLO.1 puro vectors carrying 
shRNAs for cCBL proteins were from Sigma  (MISSION shRNA). The PMDG2 and PMCV-
dR8.74 vectors to generate the lentiviral vectors were a gift from Dr. Antonio Zorzano (IRB, 
Barcelona, Spain). Antibodies: anti IRS1 (cat number 2382, 1:1000), phospho 
AKT(Ser473)(cat.number 9271, 1:1000), total AKT (cat.number 2920, 1:1000), 
phosphoERK1/2 (T202/T204) (cat.number 910,1:1000) , total ERK1/2 (p44/p42) (cat.number 
9107, 1:1000) and phosphoER (S118) (cat number 2511,1:1000) were from Cell Signalling., 
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Total ERa antibody was from Abcam (cat number ab108398,1:2000) , anti bTUBULIN 
(catalogue number T4026, 1:2000) antiACTIN(catalogue number A2066, 1:2000) antibodies 
were from Sigma-Aldrich, anti GLUT4 antibody was a gift from Dr. Jeffrey Pessin (Albert 
Einstein NY, USA) 
Animals, genotyping and diet intervention. C-Cbl null mice on C57BL6/J background were 
obtained from the National Institute of Health (USA). C57BL6/J wild type controls (WT) were 
purchased from the Jackson Laboratories (B Harbour ME, USA). Cbl null and WT animals 
were bred to obtain heterozygous animals (Cbl +/-) and the colony expanded through hetxhet 
crossings to obtain experimental cohort of animals. In all experiments age and gender wild 
type littermate control animals from our colony were used. For some experiments in addition 
to hetxhet crossings Cbl-/-x Cbl-/-  and Cbl+/+x Cbl+/+ pairs from our colony were established to 
assure enough animals per each genotype  were available. Genotypes were determined by 
PCR of genomic DNA using the following primer sets: LOXP: 5’ TGG CTG GAC GTA AAC 
TCC TCT TCA GAC CTA ATA AC 3’; CBL-10: 5’ GAC GAT AGT CCC GTG GAA GAG CTT 
TCG ACA 3’; CBL-11: 5’ CCT AAG TGG TAG GAT TAT AAT TGC AAG CCA CCA C 3’ and 
CBL-13: 5’ TCC CCT CCC CTT CCC ATG TTT TTA ATA GAC TC 3’ which amplify the 
targeted and non-targeted genes respectively. Animals were housed at 12hr light/dark cycle 
and fed at libitum with standard chow diet. Weight of animals was monitored weekly. All 
procedures were carried out in accordance with the U.K. Animal (Scientific Procedures) Act 
1986 and Home Office licenses 
Glucose and insulin tolerance tests were carried out as we previously reported (Yang, et al. 
2001) at week 12. 
 
Cells.3T3L1 cells were obtained from the ATCC. Culture and differentiation of cells was 
carried out as we described previously (Xie, et al. 2006) in cell passages <p10.Generation of 
3T3L1 cell lines stably expressing shRNAs for c-Cbl or empty PKLO puro vector or NT-




Culturing of adipose tissue explants was carried out as described (Fried and Moustaid-
Moussa 2001). Briefly, white adipose tissue was dissected and fragmented into small (1-2 
mm) pieces under sterile conditions, and subsequently incubated for 2 hours in Dulbeco 
Modified Eagle’s media (DMEM). Following the first 2 hrs of incubation, the media was 
changed to fresh DMEM and cultured further for up to 24hr. At that time insulin was added 
for 30 minutes at final concentrations  of 0nM, 1nM, 10nM and 100nM insulin (or as indicated 
in figure legends), tissues were then snap frozen in liquid nitrogen and stored at -80°C until 
analysis. 
 
Immunohistochemistry of Adipose tissue. Dissected perigonadal WAT adipose tissue was 
fixed in 4% paraformaldehyde/PBS overnight at 4°C, rinsed in PBS, dehydrated through a 
series of descending graded alcohols and embedded in paraffin. Tissue was sectioned in a 
microtome at 5-7 µm thick sections, dewaxed in histoclear (5 minutes, twice), rehydrated 
stained with Mayer’s haematoxylin (8 min), rinsed in water and acidified water (10 seconds). 
Sections were counterstained with Eosin (2 min) washed in tap water, dehydrated in 
ascending graded alcohols, cleared in xylene and mounted using DPX mounting medium. 
Sections were visualized in a Leica inverted microscope at 40x magnification and pictures 
taken with color camera. Image analysis of histological tissue preparations (cell size and 
diameter) were carried out using Image J software (NIH, USA). 
 
Tissue/cell lysate preparation and Immunoblotting. Tissue homogenates and whole cell 
lysates were obtained as previously described (Mora, et al. 2001). Briefly, tissue samples 
were homogenised in a DOUNCE glass homogenizer, in ice-cold lysis buffer (NaCl 100 mM; 
EDTA 1mM; 1% Triton x-100; NaF 50 mM; 2 mM sodium pyrophosphate; 1 mM sodium 
vanadate; 1 mM phenylmethylsulfonyl fluoride; 2 µg/ml aprotinin; 2 µg/ml pepstatin A and 2 
µg/ml leupeptin) .Samples were incubated at 4°C for 30 minutes, and centrifuged  15,300 xg 
for 15 min at 4°C). Protein concentration of the supernatant was determined using the Bio-
Rad Protein Assay Kit. Samples were separated on a SDS-PAGE, transferred to 
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nitrocellulose membranes, blotted in 5% non-fat milk in Tris-buffered saline (pH 7.6) and 
subsequently immunoblotted with primary antibodies and fluorescent labelled secondary 
antibodies IRDye 800 cw (cat number 92632210 at 1:15,000) and IRDye 680RD (cat number 
926-68071 at 1:20,000) (LICOR). Membranes were washed in Tris Buffered Saline 
containing0.1% Tween  and visualized in a LI-COR Odyssey system. Quantification of blots 
relative to reference protein as indicated in the figure legends was carried out using image J 
(NIH). 
 
ELISA determination of adipokinecontent. Adipose tissue or 3T3L1 cells were obtained in 
lysis buffer by homogenization as described above and as we reported previously (Mora et 
al. 2001). Expression of adipokines (RBP4, adiponectin, leptin,TNFa and IL6) were 
determined by ELISA using commercially available kits and antibodies (indicated above) as 
we have previously reported (Carson et al. 2013; Xie, et al. 2008). Adipokine content was 
determined in a 10 µl aliquot of lysate using standards supplied by the manufacturer and the 
results were normalized to the total protein content in the lysate as determined by Bradford.  
Plasma from tail bleeds was collected in EDTA coated tubes. The sample was centrifuged 
10 minutes at 2,000 rpm at room temperature and the supernatant containing the plasma 
was transferred to a new tube and frozen at -80ºC until used. For ELISA a 10 µl aliquot was 
used. A standard curve with recombinant protein provided by the kit was used in each assay, 
and when necessary the plasma was diluted in PBS so that the adipokine values were within 
the standard curve.  
 
Total RNA extraction and qPCR. Total RNA was isolated using Tri reagent (Sigma-Aldrich) 
following the manufacturer’s instructions. RNA was quantitated by spectrophotometry and 
visualized in an agarose gel. Total RNA was reverse transcribed to cDNA using an iScript 
cDNA synthesis kit (BIO-RAD) following the manufacturer’s instructions. Validated Taqman 
probes for Rbp4 and 18S  (assay IDs: Mn00803264-31 and Hs 99999901 respectively) were 
obtained from Life Technologies. The resulting cDNA was amplified using iTAQ probes and 
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iSCript qPCR kit (Life Technologies). Estrogen receptor isoforms α and β (accession 
numbers NM007956.5 and BC145329.1 respectively) were amplified using Kapa Sybr green 
Fast mix from Roche and the following primers: ERα: F: 5’TGATTGGTCTCGTCTGGCG3’; R: 
5’CATGCCCTCTACACATTTACC3’; ERβ: F: 5'CTGGCTAACCTCCTGATGCT3’; R: 
5'CCACATTTTTGCACTTCATGTTG3’ .The primers produce amplicons of 100 bp and 91bp 
respectively. The conditions of the reaction were: denaturation 95ºC 30 seconds, annealing 
60ºC 20 seconds, extension 72ºC 30 seconds, for 40 cycles. A melting curve was run at the 
end of each run. Relative quantification was carried out using the ΔΔCt method using 18S 
gene expression (primer sequences: forward: 5’TCAAGAACGAAAGTCGGAGG 3’ and reverse: 
5’GGACATCTAAGGGCATCACA3’:  for normalization, as we have previously reported (Yang, 
et al. 2012). 
 
Statistical analysis. Statistical analyses were carried out using GraphPad Prism 6 software 
(GraphPad software). Student t-tests or analysis of variance (ANOVA) analyses with Sidak’s 
post hoc  test were carried out as indicated in the figure legends, with a confidence interval 
of 95% and statistical significance was considered if p < 0.05. 
 
Results 
c-Cbl depletion increases whole body glucose sensitivity in male mice and alters 
adipokine expression in WAT of female mice. 
c-Cbl null mice on a Jvs129 background were shown to have reduced adiposity and 
to be more insulin sensitive than wild type mice, even on a high fat diet (Molero et al. 2004; 
Molero et al. 2006). Because the c-Cbl-/- used in our studies was generated in a C57BL6 
background, we first sought to determine growth, adiposity and in vivo whole body glucose 
tolerance and insulin sensitivity of ourmice. As shown in Fig.1A, female mice were slightly 
smaller than male mice  but there were no differences in the weight of c-Cbl-/- mice 
compared to c-Cbl+/+. We did not detect any significant differences in adipose tissue 
morphology, as revealed by eosin and hematoxylin staining of visceral adipose depots and 
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adipocyte cell size quantification (Fig.1 B and C).Similarly to what was reported previously 
(Molero et al. 2004), the null mice showed a tendency towards an increase in  glucose 
tolerance although but it did not reach statistical significance for neither gender (Fig1.D). 
Male mice however, showed improved insulin sensitivity (Fig.1E) whereas this was not 
observed in female mice.  
 
We next determined the adipokine profile expression in visceral adipose tissue and 
plasma by ELISA. In the steady state, there was a marked gender dimorphism  in the 
content of some adipokines in white adipose tissue.  In  adipose tissue of female mice, 
adiponectin levels were decreased whereas leptin and RBP4 levels were increased. No 
significant changes were observed in male Cbl-/- mice compared to Cbl+/+ mice. TNFα or IL6 
in WAT were not significantly different to those obtained in the wild type mice for either 
gender (Fig 2A). Circulating plasma levels for adiponectin, leptin or RBP4 were 
unremarkable in the Cbl null animals compared to wild type mice (Fig.2B).   
 
Despite the changes in RBP4 protein levels in white adipose tissue no significant 
changes were detected in the liver of Cbl-/- mice compared to Cbl+/+ animals (Fig.3).  
 
Depletion of c-Cbl increases ERK1/2 activation in WAT of mice and in cultured 3T3L1 
adipose cells.  
In order to determine the molecular mechanisms that may be involved in the 
upregulation of RBP4 expression in adipose tissue we examined the insulin signalling 
pathways in the adipose tissue of c-Cbl null mice and wild type animals. Expression of the 
insulin responsive substrate 1  (IRS1) or the glucose transporter GLUT4 were not altered in 
visceral WAT of null mice compared to controls (Fig4.A and B). Perigonadal visceral adipose 
tissue explants were obtained from Cbl-/- or Cbl+/+ animals and were incubated in the absence 
or presence insulin at concentrations ranging from 0 to 100nM. We then determined the 
activation of the phosphatidylinositol  3-kinase and ERK1/2 signalling pathways  by 
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monitoring the phosphorylation  levels of the downstream serine threonine kinase AKT at 
Ser473 and the phosphorylation levels of p44/p42 ERK1/2 at Thr202/204. Insulin effectively 
activated phosphatidylinositol 3 kinase and AKT to a similar extent in both c-Cbl null and wild 
type mice (Fig.4,male animals panels B, C; female animals panels D,E).  However, while 
activation of ERK1/2 proteins was achieved to a similar extent with submaximal insulin 
concentrations in the two genotypes, the c-Cbl null mice displayed a greater ERK1/2 
phosphorylation in  the  basal (untreated) state, with approximately 40% more 
phosphorylation of p44/p42 compared to the wild type (Fig.4 panels C,E). Interestingly, this 
increase in  ERK1/2 phosphorylation was not  seen in the liver (Fig.4.F). 
 
To confirm that the Cbl gene depletion was directly responsible for the increased 
basal ERK1/2 phosphorylation levels we turned to the well characterized 3T3L1 adipose cell 
line model. We postulated that if the changes in ERK1/2 signalling were solely due to the 
depletion of c-CBL in adipose cells and not an indirect or compensatory effect caused by the 
depletion of c-CBLl expression elsewhere, reduction of c-CBLexpression in the 3T3L1 cell 
line using a shRNA-mediated lentiviral approach would replicate the findings seen in  the 
adipose tissue of the mice. To this end, undifferentiated 3T3L1 cells were either left 
untreated or infected with lentiviral particles expressing either validated shRNAs for the Cbl 
gene or with lentiviral particles expressing a non-targeting shRNA (NT-shRNA) or with 
lentiviral particles containing an empty vector as an additional control. Stable cell lines were 
selected in the presence of puromycin and following amplification, the selected cells were 
differentiated to obtain fully differentiated adipocytes  as we reported previously (Carson et 
al. 2013). Of note inhibition of Cbl by shRNA did not result in changes in the differentiation of 
3T3L1 cells into adipocytes (Data not shown).   
 
Expression of c-Cbl in differentiated 3T3L1 cells was significantly reduced by the 
expression of c-Cbl shRNAs compared to control cells expressing an empty vector or a non-
targeting shRNA (NT-shRNA) (Fig.5A). Insulin treatment resulted in the activation of 
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phosphatydilinositol 3-kinase cascade and phosphorylation of AKT in Ser473 to a similar 
extent in CBL knock down cells compared to control cells (Fig 5 A and B). However, as 
detected with the primary adipose tissue of the Cbl-/- we found enhanced basal ERK1/2 
phosphorylation levels in the c-Cbl Knock down cells compared to control cells (Fig.5A and 
5B left panel). Interestingly, concomitantly with these data we found that RBP4 levels were 
significantly increased in the c-CBL knockdown cells compared to control cells. Leptin levels 
were slightly elevated in the CBL depleted cells albeit this did not reach statistical 
significance. No changes were observed in adiponectin levels compared to control cells 
(Fig.5C). 
 
Chemical inhibition of ERK1/2 decreases RBP4 expression in adipose tissue explants 
of CBL null mice and in  CBL knockdown 3T3L1  adipocytes 
Based on the above data, we postulated that the increase in ERK1/2 activation seen 
in adipocytes depleted of CBLl may be responsible for the elevated expression of RPB4. To 
test this hypothesis, we examined the effects of chemical inhibition of ERK1/2 in the adipose 
tissue explants of the Cbl null mice and in 3T3L1 Cbl KD adipocytes.   First, visceral adipose 
tissue explants were obtained and cultured in vitro in DMEM media in the absence or 
presence of two chemical inhibitors (10 µM of PD98059 and 20 µM U0126)  of MEK1/2, the 
upstream kinases that regulate ERK1/2. Subsequently, adipose tissue lysates were obtained 
and immunoblotted with antibodies for phospho-ERK1/2 to determine the level of inhibition. 
Both inhibitors significantly decreased ERK1/2 phosphorylation after 24hr treatment although 
U0126 seemed to achieve greater inhibition (Fig.6A).  We then determined the effect of this 
inhibition on RBP4 expression. Concomitantly with the reduction in ERK1/2 activation the 
content of RBP4 protein in the tissue was reduced with U0126 treatment (Fig.6B). At the 
mRNA level, treatment with both inhibitors reduced Rbp4 mRNA levels maximally after 3 hrs 
of treatment (Fig. 6C). Rbp4 mRNA levels recovered completely after 24hr following the 
treatment with PD98059 whereas a 50% decrease was still noted for U0126 at this time 
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point (Fig. 6C). As expected, the inhibitor PD98059 did not reduce the expression of Rbp4 in 
adipose tissue of wild type mice (Fig.6C). 
We confirmed this data in the 3T3L1 adipocytes cell line and found that chemical inhibition of 
ERK1/2 activation  in these cells (Fig.6D) also reduced the levels of mRNA for Rbp4 (Fig. 
6E).  
 
Estrogen receptor regulates RBP4 expression in adipocytes 
Since our findings on RBP4 expression in adipose tissue were confined to female mice and 
white adipose tissue expresses abundant ER receptors we postulated that 17β-estradiol 
may be involved in regulating RBP4. To assess this we first used UCSC Genome Browser 
(http://genome.UCSC.edu) to examine the human and mouse gene sequences. We found 
Estrogen Receptor alpha responsive elements (ERE)  in the human promoter, in an area 
that is highly conserved to the mouse gene (data not shown).This  suggested that estrogens 
may contribute to RBP4 gene regulation . To determine whether 17β-estradiol regulates 
Rbp4expression in adipocytes we treated differentiated 3T3L1 adipocytes with increasing 
concentrations (0, 1, 10 and 100 nM) of 17β-estradiol for 15hrs. Total RNA was 
subsequently harvested and mRNA levels of Rbp4 were determined by qPCR. We found 
that 17β-estradiol increased Rbp4 mRNA levels in adipocytes (Fig7A). 
 
Cbl depletion increases the phosphorylation of Estrogen receptor alpha 
Next, we questioned whether Cbl depletion in adipocytes would increase the expression or 
activation of ER receptor. We determined the expression of Era and Erb by qPCR in control 
cells and in cells stably expressing shRNAs Cbl KD. We found that the mRNA levels for ER 
receptors in Cbl depleted cells was similar to that observed in control cells (Fig.7B). 
   
Existing literature demonstrates that ERa can be activated by phosphorylation at 
Ser118, a consensus phosphorylation site for ERK1/2. We next tested whether Cbldepletion 
could result in increased phosphorylation of ERa. To this end we immunoblotted white 
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adipose tissue extracts obtained from c-Cbl-/-  and c-Cbl +/+ mice and  3T3L1 lysates obtained 
from control or CBL knock down cells,  with a phosphoERa S118 specific antibody and a 
total ERa antibody as loading control.  We found that the phospho ER (S118) levels 
normalized to total ER receptor were slightly elevated in the CBLnull mice, albeit it did not 
reach statistical significance (Fig.8A). In 3T3L1 adipocytes, CBLdepleted cells showed 
increased ER S118 phosphorylation, and as expected, this decreased dramatically upon 
exposure to MEK1 and MEK2inhibitors PD98059 and U0126 (Fig.8 B).  
 
Discussion 
CBL null mice made in the C57BL6 background did not display any significant growth 
differences compared with the wild type mice. The male mice replicated the insulin sensitivity 
phenotype described previously on the Jvs129 background (Molero et al. 2004; Molero et al. 
2006) whereas females were not significantly different than wild type. It was reported that 
CBL depletion increases muscle metabolism (Molero et al. 2004)  enhanced energy 
expenditure and reduced adiposity. The c-Cbl null mice used in our studies did not show any 
adipose tissue morphology abnormalities or differences adipocyte cell size. These findings 
suggest small differences in the phenotype that may be attributable to distinct genomic 
background. 
 
However, we detected some differences in the adipokine content of the white 
adipose tissue of female c-CBL null mice. Content of adiponectin was decreased while leptin 
and RBP4 were increased in the female Cbl-/- compared to Cbl+/+ mice. Reduced adiponectin 
levels and increased RBP4 plasma levels have been shown to correlate with states of insulin 
resistance such as obesity in both animal and humans (Tan, et al. 2007; Yang et al. 2005).  
The increase in RBP4 content was relatively small and only detected in WAT with no 
changes seen in the liver or in the circulating plasma levels. Since the liver is the main 
producer of RBP4 protein contributing to 80%  of the plasma levels, that explains the limited 
impact on circulating RBP4 and in overall insulin sensitivity. However, local changes of 
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RBP4 levels in WAT are important in determining a local inflammatory response (Moraes-
Vieira et al. 2016). Norseen et al,(Norseen et al. 2012) have recently reported that 
transgenic overexpression of RBP4 in adipose tissue increases adipose tissue inflammation 
through the activation of macrophages via JNK, TLR4 and NFkB signalling pathways. We 
did not detect any local increase in the abundance of proinflammatory cytokines IL6 or TNFa 
in WAT, which suggests RBP4 levels in the CBL null mice did not reach the threshold 
necessary to increase local macrophage inflammation response.  
 
We found increased basal activation of ERK1/2 in the adipose tissue of c-Cbl-/- mice 
and in 3T3L1 adipocyte cells depleted of c-CBL. This correlated with the increase in RBP4 
and leptin expression in adipose tissue. We did not detect any increase in the expression of 
RBP4 or raised basal ERK1/2 phosphorylation in the liver of c-Cbl-/- mice (data not shown). 
Furthermore, chemical inhibition of ERK pathway in c-CBL-depleted adipocytes decreased 
RBP4 levels. These findings suggest that c-CBL may regulate RBP4 expression through 
ERK1/2 activation. Indeed  c-CBLproteins have dual functionalities in cells. They act as 
adaptor proteins for tyrosine kinase receptors, including the insulin receptor, and recruit 
signalling proteins in the caveolae of adipose cells (Watson and Pessin 2001). In addition, c-
CBL proteins can function as an E3-ubiquitin ligase enzymes, thus facilitating the 
degradation of proteins. Molero et al.(Molero et al. 2004), had found increased insulin 
receptor expression in the skeletal muscle of Cbl-/- mice. However, we did not detect any 
changes in the expression levels of the glucose transporter GLUT4 or  IRS1 . Furthermore 
signalling through PI 3-Kinase in response to insulin was unremarkable compared to the wild 
type mice indicating equal insulin receptor substrate1 and PI 3-Kinase activation. It remains 
possible however, that the effects seen on Increased ERK1/2 activation may be dependent 
on CBL action as an E3-Ubiquitin ligase on ERK1/2 regulatory proteins, for example 
targeting an upstream ERK kinase or through an inhibitory effect of an ERK phosphatase.  
Further research is necessary to identify the molecular mechanisms for increased basal 




There was a clear gender dimorphism effect observed with RBP4 seen elevated only 
in female mice.  Similar findings were found previously in humans (Kos, et al. 2011). Both 
ERa and ERb Estrogen eceptors are present in white adipose tissue with ERa being the 
most abundant. These receptors play an important role during adipose tissue differentiation. 
Binding of estradiol to the ERa facilitates ligand-dependent activation and transactivation of 
estrogen response elements (ERE) in target genes which activate or repress gene 
expression. The human Rbp4 promoter has ERE sequences in conserved regions, which 
suggest a role for ER in the expression of RBP4, in support of this, we found that incubation 
of mouse adipose cells with 17b-estradiol increased Rbp4 mRNA levels. Our data is 
consistent with previous findings by Jung et al. (Jung, et al. 2013) who found that in 3T3L1 
adipocytes, ERa but not ERb activation increased Rbp4 mRNA levels.  
We did not determine the oestrous cycle in our female mice or indeed measured the 
circulating estradiol levels to correlate them with Rbp4 expression levels. However, the 
existing literature in human studies, have shown a correlation of RBP4 serum levels  with 
estradiol and estradiol/testosterone levels (Mohasseb and Khalil 2014) which supports the 
role of ER in the in vivo regulation of Rbp4 expression. The effects of other female hormones 
released during  the oestrous cycle on the expression of Rbp4 however, have not been 
extensively studied. A recent study in heifers showed Rbp4 mRNA and protein  levels raised 
in the endometrium during the dioestrus phase with elevated progesterone levels (Mullen, et 
al. 2012). This may be related to the role of retinoic acid signalling in the expression of 
proteins important for embryo implantation (Ma, et al. 2012).  Unfortunately, the authors did 
not measure Rbp4 levels in WAT of these animals. 
The ER receptors are members of the nuclear hormone receptor superfamily of 
transcription factors that bind ERE sequences as homo or heterodimers. ERs contain two 
transcription activation functions: AF1 located in the N terminal A/B domain and the AF2 
located in the C terminal domain. AF2 is activated through ligand (hormone) binding, 
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whereas AF1 can modulate gene transcription in the absence of ligand (Murphy, et al. 2011), 
but this is weak.  
ER activity can be modulated by intracellular signalling pathways (Barone, et al. 
2010) that phosphorylate  ERa. AKT and ERK1/2 phosphorylation sites on ERa map at S167 
for AKT and S118 for ERK1/2 both within the AF1 domain. While phosphorylation at these 
sites leads to ligand-independent activation of ERa (Murphy et al. 2011), AF1 works to 
synergize with AF2 in the promotion of ligand-dependent transcription activation by the 
receptor (reviewed byTsai and O'Malley 1994). Thus, we postulate that this mechanism may 
operate in the female CBLnull mice to enhance expression of Rbp4. Based on our findings, 
we propose that along with the increased number of ER receptors and estrogen circulating 
levels present in females, c-CBL depletion may potentiate ER activity through ERK1/2-
mediated phosphorylation of ER at S118 which results in higher RBP4 expression.  
In all our data suggest that inhibition of Cbl in adipose tissue will increase RBP4 
expression locally. We previously reported that CBL signalling is impaired in animal models 
of insulin deficiency and in obesity (Gupte and Mora 2006). While our findings need to be 
explored in the context of human adipose tissue, this study reveals a potential new 
molecular mechanism that may contribute locally to the dysregulation of RBP4 that occurs in 
obesity and insulin resistance. 
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Figure legends  
Fig. 1.A) Growth curve of wild type and CBL null mice. Data shows mean± SEM of weekly 
weight. Cbl +/+ : male n=18, female n=12; Cbl -/- : male n=14,female n=17. Statiscal analysis 
multiple t-test, not significant. B) Haematoxylin-eosin staining of perigonadal white adipose 
tissue of Cbl+/+ and Cbl -/- mice. Representative images shown of pictures obtained at 40X 
magnification of Cbl +/+ n=9 and Cbl -/- n=12 mice. Panels a and b are male and panels c and 
d are female mice. C) Quantification: Image J was used to quantify cell diameter of n=100 
cells and cell area n=50 cells per genotype and gender. Top graphs correspond to male and 
bottom to female mice Graphs show mean± SEM. Statistical Analysis: paired t-test, Not 
significant. D) Glucose tolerance test (GTT) and E) Insulin tolerance test (ITT) Tests were 
carried out at 14 weeks. Mice were injected with glucose 2 g/Kg of body weight (GTT) or 
insulin 0.75 U/Kg of body weight (ITT) and at the times indicated blood tail samples were 
obtained and glucose measured using a glucose meter. Graph show mean+ SEM of values. 
Male mice n=4, female mice n=3. Statistical analysis: paired t-test.  Area under the curve 
(AUC) p values: female:  GTT: p=0.079, ITT: p=0.442; male: GTT: p=0.428, ITT: p=0.0035  
Fig.2. Cbl -/- mice shows altered expression of adipokines in WAT of female mice.A)Tissue 
lysates were obtained from perigonadal WAT and adipokines quantified by ELISA as 
specified in the methods section. Adipokine levels were normalized by the total protein 
content in the lysate. Graphs show mean±SEM. For ADIPONECTIN,LEPTIN  and RBP4 
data from Cbl+/+: n=15 males and n=13 female mice; Cbl-/- :n=6 males and n=12 females. For 
IL6 and TNFa Cbl-/- n=4 and cbl+/+ n=10 mice. Statistical analysis: paired t-Test. * indicates 
p<0.05; ** indicates p<0.01.B) Plasma levels of adipokines. Mice were fasted for 6 hours and 
plasma drawn from the tail. Plasma adipokines were quantitated by ELISA. Graphs Show 




Fig.3. RBP4 expression in liver. Liver tissue lysates were obtained and RBP4 quantified by 
ELISA. Graphs show mean±SEM of RBP4 normalized to total protein. Cbl +/+ :male n=4, 
female n=5; Cbl -/- : male n=4,female n=8. paired t-test, * indicates p<0.05.  
 
Fig.4. Increased activation of ERK in adipose tissue of c-Cbl-/- .A) White adipose tissue 
extracts of c-Cbl+/+ and c-Cbl -/- mice were immunobloted for IRS1andGLUT4, quantification 
vs actin is shown on the right panel)B-D) White adipose tissue explants from c-Cbl+/+ and c-
Cbl -/- mice were obtained and either left untreated or treated with insulin at the indicated 
concentrations (0-100nM). Tissue extracts were obtained, loaded onto SDS PAGE and 
immunoblotted with antibodies as indicated. Panel B shows data from male mice and D) 
female mice. Panels C) and E)show quantifications of AKT and ERK1/2 phosphorylation 
relative to the total AKT or ERK1/2 protein respectively from 5 experiments. Graph shows 
Mean±SEM of phosphorylation over basal as % of Ser473(AKT) or ERK T202/204 and 
Thr185/Tyr187, respectively. Statistical analysisTwo way ANOVA with Sidak’s test, , * 
indicates p<0.05; ** indicates p<0.01. F) Liver extracts were obtained from c-Cbl+/+ and c-Cbl 
-/- mice (n=4 per group) and immunoblotted for phosphoERK1/2 and tubulin. Graph shows 
mean±SEM of the quantification over tubulin (arbitrary units).Statical analysis: t-test, not 
significant. 
 Fig.5.A) Increased activation of ERK in Cbl knockdown 3T3L1 adipocytes. Fully 
differentiated 3T3L1 adipocyte cells expressing control plasmids (empty vector (EV) or NT-
shRNA) or expressing shRNAs  for c-Cbl (CblKD)  were left untreated or stimulated with 
insulin for 20 minutes. Cellular lysates were obtained, loaded onto SDS-PAGE and 
immunoblotted with the indicated antibodies. Representative blot of 5 experiments is shown. 
B) shows the quantification in mean±SEM of intensities in arbitrary units of phospho-AKT 
(Ser473) and phospho- ERK (T202/204 and Thr185/Tyr187) respectively, obtained in 5 
independent experiments. ** indicates p<0.05. C) Knock down of Cbl in 3T3L1 adipocytes 
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increases RBP4 expression. Adipokine expression (RBP4, ADIPONECTIN and LEPTIN) 
were determined by ELISA in whole cellular lysates obtained from control (expressing empty 
vector (EV) or Non-targeting shRNAs) or Cbl KD cells (expressing shRNAs for c-Cbl). 
Graphs show the mean± SEM of N=5 sample replicates. Statistical analysis: One way 
ANOVA with Tukey’s test. ** indicates p<0.01. 
Fig.6.  Inhibition of ERK in adipose tissue explants of c-Cbl-/- mice and in Cbl depleted 3T3L1 
adipocytes reduces RBP4 levels. A) Treatment of adipose tissue explants of CBL null mice 
reduces phosphorylation of ERK. Adipose explants were treated with PD98059 or U0126 for 
24hrs. Tissue lysates were analysed by western blot. Left shows a representative blot, right 
graph shows quantification of data obtained from n=3 animals with each inhibitor. B) RBP4 
quantification by ELISA in tissue lysates of white adipose tissue explants treated with ERK 
inhibitors for 24hr. Data is the mean± SEM from n=3 mice for each inhibitor.  C) mRNA 
quantification of RBP4 in white adipose tissue explants from Cbl-/- mice left untreated or 
treated with ERK inhibitors for 3hrs or 24hrs. Graphs are mean mean± SEM of relative 
quantification to 18S as house keeping gene, data obtained from n=2 mice for each inhibitor, 
each sample quantified in triplicate. Right panel: mRNA quantification of RBP4 in white 
adipose tissue explants from Cbl+/+ mice incubated for 3hr with PD98059. D) Cbl KD 3T3L1 
adipocytes were left untreated or treated with ERK inhibitors for 15hr. Cell lysates were 
obtained and analysed by western blot. Graph is quantitation of an experiment done in 
triplicate cell dishes. Representative of two independent experiments done in triplicate. E) 
mRNA levels of Rbp4 were quantitated in Cbl Depleted 3T3L1 adipocytes left untreated or 
incubated with inhibitors for 15hrs. Graph shows mean and SEM. Representative experiment 
of n=2, with 3 biological replicates. Statistical analysis: One-Way ANOVA vs untreated with 




Fig.7. A) 17 β-estradiol increases Rbp4mRNA in 3T3l1 cells. Differentiated adipocytes were 
treated with E2 at a range of concentrations from 0 to 10-7M as indicated for 15hr. Total RNA 
was isolated and Rbp4 mRNA levels analysed by real time PCR as described in the 
methods. Graphs shows mean and SEM of n=3 cell dishes. One-Way ANOVA *** 
indicates<0.01. B) Expression of ER receptors in Cbl KD 3T3L1 cells. Total RNA was 
isolated from control or Cbl depleted 3T3L1 adipocytes and the mRNA levels of ERα and 
ERβ were determined by qPCR as described in the methods. Graphs shows mean±SEM of 
n=3 cell dishes. Statistical analysis: One way ANOVA,non-significant. 
Fig.8. Higher levels of ERa  S118 phosphorylation in Cbl depleted adipocytes. A) White 
adipose tissue extracts obtained from c-Cbl-/- or c-Cbl+/+ mice (n=3 male and n=3 female for 
each genotype) were immunoblotted with anti-phospho ERα (S118) antibody or ER antibody  
as loading control.  The blot was quantified with Image J. Graph shows mean±SEM of 
intensities in arbitrary units. Statistical analysis:ANOVA with Sidak’s multiple comparison . * 
indicates p<0.05. B) Whole cell lysates obtained from either control 3T3L1 adipocytes or Cbl 
depleted cells were immunoblotted with with anti-phospho ERa (S118) antibody or total ER 
as loading control. Graph shows a the quantification in Image J of n=3-5 replicate samples 
per group and represents the mean±SEM of phospho ERa/ER ratio in arbitrary units as % of 
control cells which do not express shRNAs for Cbl. Statistical analysis:ANOVA with 
Dunnett’s test. * indicates p<0.05 vs control. 
 
27 
 
 
28 
 
 
 
29 
 
30 
 
31 
 
 
32 
 
33 
 
 
34 
 
 
